Market Pulse Archives

Aug. 12, 2021, 7:24 a.m. EDT

CDC advisory committee to meet Friday, discuss COVID-19 booster shots

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Pfizer Inc. (PFE)
  • X
    Moderna Inc. (MRNA)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

An influential group of advisors to the Centers for Disease Control and Prevention is scheduled to meet Friday to discuss whether people who are immunocompromised should receive COVID-19 booster shots. This is the main item on the agenda for the CDC's Advisory Committee on Immunization Practices meeting , which will be webcast. Media outlets, citing anonymous sources, reported Wednesday that the Food and Drug Administration is expected to update the emergency-use authorizations for Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.48% and Moderna Inc.'s /zigman2/quotes/205619834/composite MRNA -7.40% COVID-19 shots to allow them to be used as booster shots in people with weaker immune systems.

/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 54.14
-0.81 -1.48%
Volume: 20.35M
Jan. 18, 2022 2:48p
P/E Ratio
16.08
Dividend Yield
2.95%
Market Cap
$308.43 billion
Rev. per Employee
$883,274
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 189.58
-15.15 -7.40%
Volume: 8.52M
Jan. 18, 2022 2:48p
P/E Ratio
11.62
Dividend Yield
N/A
Market Cap
$83.01 billion
Rev. per Employee
$9.10M
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.